Skip to main content

Central Lab Solutions for

Therapeutic areas and modalities

The science of drug development is boundaryless—featuring modalities not confined to a single therapeutic area and disease states with a growing menu of indications. Leverage specialized capabilities within and across your target therapeutic areas to accelerate and advance your programs.

Advanced therapeutic modalities

Partner with a central lab whose scientific capabilities keep pace with your drug development innovation

Precision medicine

As precision medicine continues to redefine the science of drug development, our investment in technology and new testing platforms has kept pace with your needs.

Scientist holding a pipette while extracting a specimen

Explore topics


Biomarkers are at the epicenter of today’s drug development and the pursuit of personalized medicines. They help define disease biology, drive patient identification and stratification, identify mechanism of action and understand the pharmacodynamic aspects of a drug.

Our scientists engage with you early in the process to better enable exploratory biomarker selection, trial design and the potential transition to companion diagnostic co-development.

Explore biomarkers

Group of cells under a microscope

Cell therapies

Adoptive cell therapies can deliver transformative approaches to patient care. Whether you are working with tumor-infiltrating lymphocytes, gene-modified T-cells expressing novel T-cell receptors, chimeric antigen receptor T-cells (CAR T) or CAR natural killer cells (CAR NK), we can support your programs across the entire development continuum. We utilize novel platforms and approaches critical to advanced therapy development, including next-generation sequencing, single-cell sequencing, digital spatial profiling and mass cytometry.

  • Discovery/preclinical
  • GMP CMC release
  • Clinical trial testing (including special logistics services)
  • Global resources network

Gene therapies

Reach your development goals on time and within budget leveraging our gene therapy expertise and resources, whether you’re developing a viral vector-based therapy or applying gene editing technologies.

  • Discovery/preclinical
  • GMP CMC release
  • Clinical trial testing
  • Global resources network and manufacturing partnerships
Female Scientist researcher using microscope in laboratory. Medical healthcare technology and pharmaceutical research and development concept.


Vaccine trials bring unique challenges that require more flexible solutions, including lab adaptability and scale. For large vaccine trials, like we saw for COVID-19 vaccines in the early 2020s, fast enrollment of 20,000-50,000 patients in 1-3 months generates tremendous pressure on kits, logistics, specimen storage and lab capacity. These multinational “follow the virus” trials frequently have numerous protocol amendments and short timelines for specimen processing. Labcorp’s central lab has a vaccines trial track record you can trust.

  • Microbiology
  • Immunology
  • Integrated capabilities with nonclinical, bioanalytical services teams
  • Purpose-built vaccines and novel immunotherapeutics lab (Indianapolis, IN)

Companion diagnostics (CDx)

Precision medicine demands patient stratification—requiring identification of patients more likely to benefit from therapy. CDx also enables reduced development time and Rx development costs and can result in more favorable reimbursement and illustrate comparative effectiveness.

  • In vitro diagnostic (IVD) or laboratory-developed tests (LDTs)
  • Deep and diverse biomarker expertise
  • Informed regulatory guidance with a market access strategy
  • Global reach and consistency to drive CDx validation
Scientis extracing sample from vail

Therapeutic area experience

No matter what therapeutic area or disease indication your program is focused on, rely on our extensive, documented clinical trial experience across all therapeutic indications. 

Explore key therapeutic areas

Let's start a conversation